All In Biotech

Free tool

FAERS Monitor: Perjeta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125409 or its brand name (Perjeta, Pertuzumab). Reports on generic versions are filed under their own applications.

Reports

27,608

Serious

23,433

85% of reports

Hospitalization

9,313

Death reported

2,728

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea3,873
  • off label use2,424
  • nausea1,996
  • fatigue1,951
  • myelosuppression1,628
  • alopecia1,587
  • disease progression1,380
  • vomiting1,323
  • dyspnoea1,213
  • neuropathy peripheral1,146
  • death1,119
  • pyrexia1,078
  • neutropenia1,027
  • rash963
  • anaemia901

Reports by year received

View as table
YearReports
20051
20096
201019
201122
2012128
2013679
2014734
2015922
20161,184
20171,909
20182,175
20192,290
20202,531
20212,951
20222,699
20232,753
20243,065
20252,025
20261,515

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,551 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal1,62836.034.352,979
neuropathy peripheralSignal1,1469.38.88,392
disease progressionSignal1,3809.08.59,716
alopeciaSignal1,5876.25.96,923
neutropeniaSignal1,0275.85.54,061
diarrhoeaSignal3,8734.64.511,158
anaemiaSignal9013.63.41,706
pyrexiaSignal1,0782.42.2871
vomitingSignal1,3232.12.0826
off label useSignal2,4242.12.01,476
nausea1,9961.91.8917
fatigue1,9511.91.8877
rash9631.71.6272
dyspnoea1,2131.61.5305
death1,1191.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.